IgG antibody responses in early experimental sparganosis and IgG subclass responses in human sparganosis.

Antigenic components in the crude extracts of Spirometra mansoni plerocercoid were analyzed in early experimental infections and in IgG subclass observed in clinical sparganosis. By IgG immunoblot, sera obtained serially from experimental mice, fed 5 spargana each, were reacted with the crude extracts. Protein bands at 36-26 kDa and 103 kDa showed positive reactions since two weeks after infection. In a differential immunoblot, in which a monospecific antibody against sparganum chymase at 36 kDa was pre-treated, the reactions at 36-26 kDa disappeared, indicating that the sparganum chymase and its degradation products invoked IgG antibody reactions. When 69 patients sera of human sparganosis were examined for their IgG subclass responses, IgG4 levels showed the highest reaction which was followed by IgG1. The IgG4 antibody also reacted mainly with 36-31 kDa protease. These results indicate that 36 kDa chymase of S. mansoni plerocercoid is the main antigenic component inducing IgG antibody response in early stage of experimental sparganosis and for specific IgG subclass reactions in human sparganosis.
AuthorsY B Chung, Y Kong, H J Yang, S Y Cho
JournalThe Korean journal of parasitology (Korean J Parasitol) Vol. 38 Issue 3 Pg. 145-50 (Sep 2000) ISSN: 0023-4001 [Print] KOREA (SOUTH)
PMID11002649 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Helminth
  • Antigens, Helminth
  • Immunoglobulin G
  • Serine Endopeptidases
  • Chymases
  • Animals
  • Antibodies, Helminth (blood)
  • Antigens, Helminth (immunology)
  • Chymases
  • Humans
  • Immunoblotting
  • Immunoglobulin G (blood, classification)
  • Mice
  • Mice, Inbred ICR
  • Molecular Weight
  • Serine Endopeptidases (immunology)
  • Sparganosis (immunology)
  • Sparganum (enzymology, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: